Airgain Reports Significant Q4 and Full Year 2025 Financial Decline, Issues Lower Q1 2026 Guidance
summarizeSummary
Airgain announced Q4 and full year 2025 financial results showing significant revenue declines and increased net losses, alongside Q1 2026 guidance that projects further sequential sales contraction and continued losses, despite a strategic acquisition.
check_boxKey Events
-
Q4 2025 Sales Decline
Reported sales of $12.1 million for Q4 2025, representing a 13.5% sequential decrease from Q3 2025 and a 19.6% year-over-year decrease from Q4 2024.
-
Widening Net Loss
GAAP net loss for Q4 2025 was $2.4 million, or $(0.20) per share, an increase from the $1.0 million net loss in Q3 2025 and $2.0 million net loss in Q4 2024.
-
Lower Q1 2026 Guidance
Forecasted Q1 2026 sales between $10.5 million and $12.5 million (midpoint $11.5 million), indicating continued sequential decline, with an expected GAAP net loss of $(0.17) per share at the midpoint.
-
Strategic Product Line Acquisition
Acquired the HPUE product line assets from Nextivity in February 2026, a strategic move aimed at strengthening its system-level connectivity portfolio and vehicle gateway capabilities.
auto_awesomeAnalysis
Airgain reported a substantial decline in sales for both the fourth quarter and full year 2025, accompanied by widening net losses. The company's guidance for the first quarter of 2026 projects further sequential sales contraction and continued losses. While the acquisition of Nextivity's HPUE product line offers a strategic expansion of its connectivity portfolio, the immediate financial outlook presents significant challenges, indicating a critical need for successful commercialization of its new platforms to reverse the declining revenue trend.
At the time of this filing, AIRG was trading at $4.64 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $55.4M. The 52-week trading range was $3.00 to $6.74. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.